GO:0061369 negative regulation of testicular blood vessel morphogenesis: Vascular Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061369 describes any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.
• It is a biological_process term that acts as a negative regulator of testicular vasculature development, helping to keep testicular angiogenesis in check.
• Disruption of this regulatory process is relevant to testicular tumors such as juvenile granulosa cell tumors of the testis, which show a wide morphologic spectrum.
• Key research tools include knockout, knock-in, overexpression cell models and CRISPR library screening to dissect the genetic control of testicular vascular morphogenesis.
• Understanding GO:0061369 supports studies of testicular development, fertility, and tumor angiogenesis.
• EDITGENE provides CRISPR-based services to model and analyze genes involved in this process.
Description
GO:0061369, negative regulation of testicular blood vessel morphogenesis, is a Gene Ontology biological_process term that captures the cellular and molecular events that restrain the formation of new blood vessels within the testicle. Blood vessel morphogenesis is essential for delivering oxygen and nutrients to the developing and adult testis, but it must be tightly controlled to avoid pathological angiogenesis. This term specifically refers to the inhibitory arm of that control, encompassing signals that stop, prevent, or reduce the frequency, rate or extent of testicular blood vessel morphogenesis. For researchers, GO:0061369 provides a standardized way to annotate genes and pathways that suppress testicular angiogenesis. Because testicular tumors such as juvenile granulosa cell tumors of the testis can display a wide morphologic spectrum, including vascular patterns, understanding the negative regulation of testicular blood vessel morphogenesis may offer insights into tumor biology and normal testicular function. This article summarizes the definition, biological context, key genes, disease links, and research methods relevant to GO:0061369, with a focus on how CRISPR-based models can be used to study this process.
negative regulation of testicular blood vessel morphogenesis At A Glance
| GO ID | GO:0061369 |
|---|---|
| GO term | negative regulation of testicular blood vessel morphogenesis |
| Ontology | biological_process |
| Synonym | negative regulation of testicular vasculature morphogenesis |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle |
| Process type | Negative regulation of a developmental morphogenesis process |
| Anatomical context | Testicle |
| Biological outcome | Suppression of testicular angiogenesis and vascular remodeling |
What Is GO:0061369?
In simple terms, GO:0061369 is the brake that slows down or stops the growth of new blood vessels in the testicle. According to the Gene Ontology, it is any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle. It is a biological_process term, and its synonym is negative regulation of testicular vasculature morphogenesis.
Why Is negative regulation of testicular blood vessel morphogenesis Important in Cell Biology?
GO:0061369 is important because balanced control of blood vessel formation in the testis is critical for normal testicular development, hormone production, and fertility, while excessive or dysregulated angiogenesis can contribute to testicular pathology, including tumors such as juvenile granulosa cell tumors of the testis that exhibit a wide morphologic spectrum. Studying this negative regulatory process helps researchers identify molecular brakes on testicular angiogenesis and evaluate their roles in disease.
• Maintains vascular homeostasis in the testis by preventing excessive blood vessel morphogenesis.
• Supports normal testicular development and function, including spermatogenesis and hormone production.
• Dysregulation may contribute to testicular tumor angiogenesis and progression.
• Provides a framework for annotating genes that suppress angiogenesis in reproductive tissues.
• Helps interpret morphologic diversity in testicular tumors such as juvenile granulosa cell tumors.
• Guides CRISPR-based functional studies of testicular vascular regulators.
• Relevant to fertility research and reproductive toxicology.
• Offers potential targets for anti-angiogenic strategies in testicular cancers.
What Happens During negative regulation of testicular blood vessel morphogenesis?
Initiation of negative regulatory signals
In simple terms: The body sends stop signals to the cells that would otherwise build new blood vessels in the testicle.
Negative regulation of testicular blood vessel morphogenesis begins when inhibitory signals are produced or activated in the testicular microenvironment. These signals can originate from supporting cells, extracellular matrix components, or soluble factors that counteract pro-angiogenic cues. In the context of testicular tumors such as juvenile granulosa cell tumors, the morphologic spectrum may reflect varying degrees of such regulatory activity.
Suppression of endothelial cell activation
In simple terms: The stop signals prevent endothelial cells from becoming active and forming new tubes.
A key step in this process is the suppression of endothelial cell activation, proliferation, and migration within the testis. Negative regulators can interfere with pro-angiogenic signaling pathways, thereby reducing the frequency and extent of blood vessel morphogenesis. This helps maintain a stable vascular network in the testicle.
Inhibition of vessel sprouting and tube formation
In simple terms: Even if some endothelial cells try to sprout, the negative regulators block them from forming complete vessels.
Negative regulation of testicular blood vessel morphogenesis also acts at the level of vessel sprouting and tube formation. Inhibitory molecules can prevent endothelial cells from organizing into functional capillaries, thus reducing the rate of new vessel formation. This step is critical for preventing excessive angiogenesis in the testis.
Maintenance of vascular quiescence
In simple terms: The final result is that the testicular blood vessels stay quiet and do not grow unnecessarily.
The ultimate outcome of GO:0061369 is the maintenance of vascular quiescence in the testicle, where blood vessel morphogenesis is kept at a low rate. This balance is essential for normal testicular physiology and may be disrupted in pathological conditions such as testicular tumors. Juvenile granulosa cell tumors of the testis, for example, can show a wide morphologic spectrum that may include vascular features influenced by such regulatory processes.
Key Genes Involved in GO:0061369 negative regulation of testicular blood vessel morphogenesis
The following genes and proteins have been implicated in the regulation of testicular blood vessel morphogenesis or are relevant to testicular vascular biology, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Pro-angiogenic factor; its inhibition contributes to negative regulation | Target for studying suppression of testicular angiogenesis |
| KDR (VEGFR2) | Receptor for VEGF; signaling blockade reduces vessel morphogenesis | Key node in negative regulatory pathways |
| FLT1 (VEGFR1) | Decoy receptor that sequesters VEGF | Potential negative regulator of testicular angiogenesis |
| ANGPT2 | Antagonist of ANG1; destabilizes vessels | May inhibit vessel stabilization in testis |
| THBS1 | Anti-angiogenic matricellular protein | Candidate negative regulator in testicular tissue |
| SERPINF1 | Potent anti-angiogenic factor | May suppress testicular blood vessel morphogenesis |
| TIMP3 | Inhibitor of metalloproteinases | Can limit vascular remodeling |
| DLL4 | Notch ligand; modulates sprouting angiogenesis | Involved in negative feedback on vessel growth |
| NOTCH1 | Receptor in DLL4-NOTCH signaling | Mediates inhibitory signals in angiogenesis |
| HIF1A | Oxygen-sensing transcription factor | Regulates pro- and anti-angiogenic genes |
| PEDF (SERPINF1) | Anti-angiogenic factor | Studied in reproductive tissues |
| CXCL10 | Chemokine with anti-angiogenic properties | Potential negative regulator |
| IL12 | Cytokine that inhibits angiogenesis | May influence testicular vascularity |
| TSP1 (THBS1) | Anti-angiogenic protein | Model for negative regulation studies |
| VASH1 | Vasohibin; negative feedback regulator of angiogenesis | Candidate for testicular vascular control |
| VASH2 | Vasohibin family member | May modulate angiogenesis |
| ADAMTS1 | Metalloproteinase with anti-angiogenic activity | Potential role in testicular vessel morphogenesis |
How Is negative regulation of testicular blood vessel morphogenesis Regulated?
The negative regulation of testicular blood vessel morphogenesis is itself controlled by a balance of pro- and anti-angiogenic factors, including oxygen-sensing pathways such as HIF1A and feedback loops involving Notch signaling. In testicular tumors like juvenile granulosa cell tumors, the morphologic spectrum may reflect alterations in these regulatory circuits.
negative regulation of testicular blood vessel morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VEGFA | Testicular tumor angiogenesis | Knockout or knockdown in testicular cell lines |
| KDR | Vascular overgrowth in testis | Point mutation to block ligand binding |
| THBS1 | Loss of anti-angiogenic brake | Overexpression in testicular endothelial cells |
| SERPINF1 | Dysregulated angiogenesis | Knock-in of tagged protein for imaging |
| DLL4 | Altered Notch signaling in testicular tumors | CRISPR knockout in organoid models |
Testicular tumors and vascular morphology
Juvenile granulosa cell tumors of the testis are rare tumors that display a wide morphologic spectrum, including patterns that may involve vascular structures. Dysregulation of negative regulation of testicular blood vessel morphogenesis could contribute to the vascular phenotype observed in such tumors.
Impaired fertility and testicular dysfunction
Excessive or insufficient testicular angiogenesis can affect testicular function and fertility. Proper negative regulation of blood vessel morphogenesis is therefore important for reproductive health.
Angiogenesis-related pathologies
Beyond the testis, imbalances in negative regulation of angiogenesis are relevant to a broad range of diseases, and studying GO:0061369 may provide insights into general principles of vascular control.
From negative regulation of testicular blood vessel morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate testicular blood vessel morphogenesis? | Knockout cell model (e.g., endothelial or testicular cells) |
| Does a specific mutation in gene X alter its anti-angiogenic function? | Point mutation knock-in cell model |
| Can we visualize gene X protein dynamics in testicular vessels? | Tagged knock-in (e.g., GFP) |
| Does overexpression of gene X suppress angiogenesis? | Overexpression cell model |
| Which genes are essential for negative regulation in testis? | CRISPR library screening |
| What are the transcriptomic changes upon gene X knockout? | RNA-seq and bioinformatics analysis |
How to Study the negative regulation of testicular blood vessel morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Testing if a gene negatively regulates testicular angiogenesis |
| RNA-seq | Transcriptome changes | Identifying pathways altered upon gene perturbation |
| Bioinformatics | Pathway enrichment | Interpreting large datasets from CRISPR screens |
| Immunofluorescence | Protein localization and vessel density | Visualizing blood vessels in testis |
| Western blot | Protein expression levels | Validating knockout or overexpression |
| Co-IP | Protein-protein interactions | Mapping signaling complexes |
| Luciferase reporter | Transcriptional activity | Assessing promoter regulation |
| Organoid culture | 3D tissue architecture | Modeling testicular vasculature |
CRISPR knockout and screening
CRISPR knockout models can be used to delete candidate negative regulators and assess their effect on testicular blood vessel morphogenesis. Pooled CRISPR library screening allows unbiased identification of genes that suppress angiogenesis in testicular cells.
Transcriptomics and bioinformatics
RNA-seq followed by bioinformatics analysis can reveal gene expression changes associated with altered negative regulation of testicular blood vessel morphogenesis. Pathway enrichment can highlight angiogenesis-related networks.
Imaging and morphometry
Imaging of testicular tissue or in vitro models can quantify vessel density and morphology, providing functional readouts for negative regulation. Morphometric analysis is particularly relevant for characterizing the wide morphologic spectrum of testicular tumors.
Protein interaction and signaling assays
Co-immunoprecipitation, Western blotting, and reporter assays can dissect the molecular mechanisms by which negative regulators inhibit pro-angiogenic signaling.
How CRISPR Can Be Used to Study GO:0061369 negative regulation of testicular blood vessel morphogenesis
Knockout
CRISPR knockout of candidate genes in testicular or endothelial cell lines can determine whether they are required for the negative regulation of testicular blood vessel morphogenesis. Loss-of-function models help establish causality.
Point Mutation
Point mutation knock-in can mimic disease-associated variants or disrupt specific functional domains of negative regulators, allowing precise structure-function studies.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) enables real-time monitoring of gene expression and protein localization during testicular vascular morphogenesis.
Overexpression
Overexpression of anti-angiogenic factors in testicular cells can test whether increased levels suppress blood vessel morphogenesis.
How EDITGENE Supports negative regulation of testicular blood vessel morphogenesis Research
Researchers studying negative regulation of testicular blood vessel morphogenesis-related genes often need to determine whether a candidate gene is causally involved in suppressing angiogenesis. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of testicular blood vessel morphogenesis research.
Frequently Asked Questions About negative regulation of testicular blood vessel morphogenesis
What is GO:0061369?
GO:0061369 is the Gene Ontology term for negative regulation of testicular blood vessel morphogenesis, defined as any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.
What genes are involved in negative regulation of testicular blood vessel morphogenesis?
Genes such as VEGFA, KDR, FLT1, THBS1, SERPINF1, and DLL4 have been implicated in the regulation of angiogenesis and may play roles in this process.
Why is negative regulation of testicular blood vessel morphogenesis important?
It helps maintain vascular homeostasis in the testis and prevents excessive angiogenesis, which is relevant to testicular tumors and fertility.
How can I study GO:0061369 in the lab?
CRISPR knockout, knock-in, overexpression models, and CRISPR library screening combined with RNA-seq and imaging are common approaches.
What diseases are linked to testicular blood vessel morphogenesis?
Juvenile granulosa cell tumors of the testis and other testicular pathologies may involve dysregulated angiogenesis.
What is the synonym for GO:0061369?
The synonym is negative regulation of testicular vasculature morphogenesis.
Which ontology aspect does GO:0061369 belong to?
It belongs to the biological_process aspect of the Gene Ontology.
Can CRISPR be used to study testicular angiogenesis?
Yes, CRISPR knockout and screening are powerful tools to identify and validate genes that regulate testicular blood vessel morphogenesis.
What cell models are suitable for studying GO:0061369?
Testicular cell lines, endothelial cells, and organoid models can be used to study this process.
How does EDITGENE support research on GO:0061369?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
GO:0061369, negative regulation of testicular blood vessel morphogenesis, is a critical biological process that restrains angiogenesis in the testis. Understanding its molecular players and regulatory mechanisms can shed light on testicular development, fertility, and diseases such as juvenile granulosa cell tumors of the testis. By leveraging CRISPR-based models and EDITGENE's services, researchers can systematically dissect the genes and pathways that control this process, accelerating discoveries in reproductive biology and oncology.
References
- 1. Kao CS et al.. 2015. Juvenile granulosa cell tumors of the testis: a clinicopathologic study of 70 cases with emphasis on its wide morphologic spectrum.. Am J Surg Pathol 39(9):1159-69 PMID: 26076062
